Celecoxib Compared With No Treatment Before Surgery in Treating Patients With Localized Prostate Cancer
Status:
Completed
Trial end date:
2005-01-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Celecoxib may be an effective treatment for early stage prostate cancer. It is not
yet known if celecoxib is more effective than no treatment before surgery for prostate
cancer.
PURPOSE: Randomized phase I trial to determine the effectiveness of celecoxib given before
surgery to remove the prostate in treating patients who have localized prostate cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins